Lymphoma, non-hodgkin Trials in Boston, United States
Conditions / Lymphoma, non-hodgkin / Boston, United States
Research into Lymphoma, non-hodgkin spans multiple therapeutic approaches and trial phases.
33 total trials for this combination
Showing top 10 of 33 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03229200 | Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib. | ACTIVE_NOT_RECRUITING | PHASE4 |
| NCT00001120 | A Study of Patients With AIDS Syndrome | COMPLETED | — |
| NCT04136275 | CAR-37 T Cells in Hematologic Malignancies | COMPLETED | PHASE1 |
| NCT00000658 | A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma | COMPLETED | PHASE3 |
| NCT02703272 | A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma | TERMINATED | PHASE3 |
| NCT05024045 | Study of Oral LOXO-338 in Patients With Advanced Blood Cancers | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT07101328 | A Study of LY4152199 in Participants With Previously Treated B-cell Cancers (BAF_FRontier-1 ) | NOT_YET_RECRUITING | PHASE1 |
| NCT04637763 | CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER) | RECRUITING | PHASE1 |
| NCT03575351 | A Study to Compare the Efficacy and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas | COMPLETED | PHASE3 |
| NCT00000801 | Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma | COMPLETED | PHASE2 |